Larissa Meyer (@larissaameyermd) 's Twitter Profile
Larissa Meyer

@larissaameyermd

ID: 1095729189095915520

calendar_today13-02-2019 16:59:31

78 Tweet

430 Followers

514 Following

Emil Lou, MD, PhD, FACP (@cancerassassin1) 's Twitter Profile Photo

Oncologists, of all ages and stages of your career: lend us your ears (and voices). ASCO wants to know what it can do to help with your professional development. Will you fill our short survey so our #ASCOLDP team can give feedback by #ASCO22? surveymonkey.com/r/LDP2122 #ASCOLDP21

Larissa Meyer (@larissaameyermd) 's Twitter Profile Photo

Serving myself a bowl right now liz swisher celebrating you and the amazing contributions you have made to gyn cancers #everydaysexism #IWD2022 #BreakTheBias

Michael Frumovitz (@frumovitz) 's Twitter Profile Photo

Our trial with immunotherapy AK104 (cadonilimab) for women with neuroendocrine cervix cancer at MD Anderson Cancer Center opened just this week! We already have 1 enrolled and 2 in screening. Trials for #raretumors are possible! SGO NANETS SCCC/LCCC Sisterhood Shannon Westin, MD, MPH, FASCO Karen Lu

Gregg Nelson (@greggnelsoneras) 's Twitter Profile Photo

10 days until Master Class: Optimize and Operate SGO Mar 18 #SGO2022Phoenix 👏 🎉 Come for exciting talks on #ERAS #MBP #Frailty #VTE #Anesthesia #PROMs #OpioidReduction #SameDayDischarge #Equity #Multidisciplinary #Surgery

Pedro T Ramirez (@pedroramirezmd) 's Twitter Profile Photo

Not yet!….Updates on final analysis of #LACC Trial will be presented this afternoon in the #SGOMtg Late Breaking Session …Hope to see you there or that you tune in virtually #cervicalcancer SGO MD Anderson Cancer Center Thales P. Batista, MD, PhD IJGC IJGC Fellows ESGO SoMe4GynOnc

Shannon Westin, MD, MPH, FASCO (@shannonwestin) 's Twitter Profile Photo

Answering a critical ❓in #EndometrialCancer: ✅All pts w/ initial mismatch repair deficiency retained this aberration in recurrence. ‼️9% developed MMRd in the recurrent setting. 👍Great job Rebecca Previs - this has potential to guide our testing strategies #SGOMtg #gyncsm

Answering a critical ❓in #EndometrialCancer: 
✅All pts w/ initial mismatch repair deficiency retained this aberration in recurrence.  
‼️9% developed MMRd in the recurrent setting. 
👍Great job <a href="/BeccaPrevisMD/">Rebecca Previs</a> - this has potential to guide our testing strategies #SGOMtg #gyncsm
Peter WT Pisters, MD (@ppisters) 's Twitter Profile Photo

Thrilled to see Karen Lu recognized by AACR for her impactful contributions to cancer care, research and training. Her leadership at MD Anderson Cancer Center, as well as on the national and international oncology stage, will continue to benefit patients for decades to come. #EndCancer

Jocelyn J. Fitzgerald MD (@jjfitzgeraldmd) 's Twitter Profile Photo

Imagine taking an oath to do no harm that you can no longer keep. OB/GYNs are often the the only wall standing between women and death. We are not ok today.

Iakovos Toumazis 🇨🇾 (@itoumazis) 's Twitter Profile Photo

Important insights on #ovarian cancer preclinical phase may explain why annual screening is not effective in reducing mortality. Read more in our recent paper 👇 academic.oup.com/jnci/article-a… Larissa Meyer Karen Lu MD Anderson Cancer Center